Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$12.35 - $19.33 $222 - $347
-18 Reduced 69.23%
8 $0
Q4 2023

Feb 14, 2024

BUY
$12.87 - $19.09 $90 - $133
7 Added 36.84%
26 $0
Q4 2023

Feb 14, 2024

SELL
$12.87 - $19.09 $90 - $133
-7 Reduced 26.92%
19 $0
Q2 2023

Aug 16, 2023

SELL
$21.6 - $30.69 $379,382 - $539,039
-17,564 Reduced 99.85%
26 $1,000
Q1 2023

May 11, 2023

BUY
$23.07 - $32.77 $405,201 - $575,572
17,564 Added 67553.85%
17,590 $610,000
Q4 2022

Feb 08, 2023

SELL
$25.29 - $35.48 $303 - $425
-12 Reduced 31.58%
26 $1,000
Q3 2022

Nov 15, 2022

SELL
$24.0 - $33.42 $648 - $902
-27 Reduced 41.54%
38 $1,000
Q2 2022

Aug 10, 2022

BUY
$24.78 - $33.36 $1,610 - $2,168
65 New
65 $2,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Resources Management Corp Portfolio

Follow Resources Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Resources Management Corp with notifications on news.